Targeting sirtuin-1 in Huntington's disease: rationale and current status.

@article{Duan2013TargetingSI,
  title={Targeting sirtuin-1 in Huntington's disease: rationale and current status.},
  author={Wenzhen Duan},
  journal={CNS drugs},
  year={2013},
  volume={27 5},
  pages={345-52}
}
Huntington's disease (HD) is an autosomal dominant hereditary disease caused by a trinucleotide repeat mutation in the huntingtin gene that results in an increased number of glutamine residues in the N terminus of huntingtin protein. Mutant huntingtin leads to progressive impairment of motor function, cognitive dysfunction, and neuropsychiatric disturbance. There are no disease-modifying treatments available. During the past decade, sirtuin-1 (SIRT1) has been the focus of intense investigation… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…